Effects Of Breath And Stacking-Spirometry Incentive in Patients With Parkinson's Disease

August 29, 2013 updated by: Daniella Cunha Brandao, Universidade Federal de Pernambuco

EFFECTS OF BREATH AND STACKING-SPIROMETRY INCENTIVE PACKAGES IN THE RIB CAGE IN PATIENTS WITH PARKINSON'S DISEASE

Objective: To evaluate the effects of technical-Breath Stacking (BS) and incentive spirometry (IS) on the volume of the chest immediately after and within thirty minutes after the techniques in patients with Parkinson's disease (PD). Methods: This is a study of cross-over. The study investigated 14 patients with mild to moderate PD. The subjects performed the technique Breath-Stacking, incentive spirometry volume and participated in a phase control according to randomization. The volunteers were evaluated by opto-electronic plethysmography in four stages: before, immediately after fifteen and thirty minutes after the completion of the techniques. The investigators used a repeated measures ANOVA with post-hoc Tukey test for parametric variables, and the Friedman test with post-hoc Dunns for nonparametric variables. The level of significance was set at 5%, p <0.05.

Study Overview

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pernambuco
      • Recife, Pernambuco, Brazil, 50670-901
        • Universidade Federal de Pernambuco
      • Recife, Pernambuco, Brazil
        • Departamento de Fisioterapia-Universidade Federal de pernambuco

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Regular pharmacological treatment with levodopa and / or medications antiparkinsonian.

Exclusion Criteria:

  • Patients who had previous lung disease;
  • Altered mental status indicated by the MMSE (Mini Mental State Examination;
  • A change in medication during the study;
  • Demonstrated inability to perform satisfactorily any of the collection procedures of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Control Group
EXPERIMENTAL: Incentive spirometry
Was utilized an incentive spirometer volume in this group.
We used an incentive spirometer volume (5000 Voldyne ® Sherwood Medical, USA). Subjects performed slow, deep inhalations from functional residual capacity to total lung capacity, seeking to sustain the inspiration for at least three seconds (Restrepo et al., 2011).
EXPERIMENTAL: Breath Stacking
We used a face mask silicone connected to a check valve allowing only inspiration and is connected to a spirometer showed that the volume inspired by the individual.
We used a silicone face mask, connected to a unidirectional valve which allowed only inspiration and is connected to a spirometer showed that the volume inspired by the individual. The face mask was attached to the appraised performed successive breaths until the researcher realized the lack of volume of air being inhaled and this time it was allowed to expire (Baker et al., 1990; Feitosa et al., 2012).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The variation of the total volume and compartmental between technique Breath-Stacking in patients with Parkinson's disease
Time Frame: 25 days
25 days
The variation of the total volume and compartmental in the technique incentive spirometry in patients with Parkinson's disease
Time Frame: 25 days
25 days

Secondary Outcome Measures

Outcome Measure
Time Frame
The duration of the effects of technical-Breath Stacking and incentive spirometry in patients with Parkinson's disease
Time Frame: 25 days
25 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: RHAYSSA RH RIBEIRO, Msc, Universidade Federal do Rio Grande do Norte

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2012

Primary Completion (ACTUAL)

June 1, 2012

Study Completion (ACTUAL)

December 1, 2012

Study Registration Dates

First Submitted

July 9, 2013

First Submitted That Met QC Criteria

August 29, 2013

First Posted (ESTIMATE)

August 30, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

August 30, 2013

Last Update Submitted That Met QC Criteria

August 29, 2013

Last Verified

December 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson's Disease.

Clinical Trials on Incentive spirometry

3
Subscribe